Difficulty: Medium
Average Score: 79%
Practice
Which of the following is an appropriate intervention for a neonate with neonatal abstinence syndrome (NAS)?
Correct answer
B
Rationale
Neonatal Abstinence Syndrome (NAS) occurs in newborns exposed to addictive substances in utero, most commonly opioids. Morphine or methadone therapy is the appropriate intervention for a neonate with NAS because it helps manage withdrawal symptoms in a controlled manner, ensuring the infant's safety and comfort during detoxification. These medications are titrated based on the infant's symptoms, reducing the risk of seizures and other complications associated with withdrawal.
Nutritional support is essential for infants with NAS to promote growth and development, but it does not directly address the withdrawal symptoms. Antibiotic therapy is not indicated unless there is a concurrent infection present. Continuous positive airway pressure is used for respiratory support and would not directly address the symptoms of NAS.
Educationally, it is crucial for nursing students preparing for the NCLEX to understand the specific interventions and management strategies for neonates with NAS. This knowledge ensures safe and effective care for this vulnerable population, emphasizing the importance of pharmacological interventions tailored to the infant's needs and withdrawal symptoms. It also highlights the importance of monitoring and assessing neonates with NAS closely to provide individualized care.
Nutritional support is essential for infants with NAS to promote growth and development, but it does not directly address the withdrawal symptoms. Antibiotic therapy is not indicated unless there is a concurrent infection present. Continuous positive airway pressure is used for respiratory support and would not directly address the symptoms of NAS.
Educationally, it is crucial for nursing students preparing for the NCLEX to understand the specific interventions and management strategies for neonates with NAS. This knowledge ensures safe and effective care for this vulnerable population, emphasizing the importance of pharmacological interventions tailored to the infant's needs and withdrawal symptoms. It also highlights the importance of monitoring and assessing neonates with NAS closely to provide individualized care.